Mary Norine Walsh, MD, immediate past president of the American College of Cardiology, discusses the risks for pregnant women with hypertension.
Mary Norine Walsh, MD, immediate past president of the American College of Cardiology, discusses the risks for pregnant women with hypertension.
Transcript
What special concerns do pregnant women have with hypertension? What signs should they look for if they have not experienced hypertension in the past?
One of the focuses of that particular paper in [the Journal of American College of Cardiology] JACC was hypertension across a woman's life cycle. The reason that this is important— in particular in pregnancy– [is that] there are several different issues that women need to think about. One is if a woman has pre-existing hypertension going into pregnancy, that's one issue and the hypertension has to be well controlled during the pregnancy.
But, an even bigger concern often is a woman who develops hypertension during pregnancy and/or preeclampsia. [This is] because what we know is that any level of hypertension during pregnancy, or the preeclamptic state, predicts for women a higher risk going forward of developing cardiovascular disease later on in her life.
In addition to the obstetric clinicians as well as internal medicine, family medicine, and even cardiologists who a woman might see, she really needs to be aware of her own blood pressure and to be asking those questions during the monitoring of her pregnancy as to "What is my blood pressure, do I have signs of preeclampsia, are there conditions that I need to worry about?"
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas
December 5th 2024On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More